Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: The aging heart in health: Links to heart disease

Circulation

Volumn 107, Issue 2, 2003, Pages 346-354

  Lakatta, Edward G ^a,b,c   Levy, Daniel ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE;

AGED; AGING; ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL STRUCTURE; HEART AFTERLOAD; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART RATE; HEART RHYTHM; HUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW;

AGING; ARTERIES; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; HEART; HUMANS; MALE; MYOCARDIUM; PREVALENCE; RISK FACTORS;

EID: 0037458070     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000048893.62841.F7     Document Type: Review

References (37)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
2. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study [see comments]. J Am Coll Cardiol. 1991;18:1287-1294.
3. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1992;19:130-134.
4. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
5. Haider AW, Larson MG, Benjamin EJ, et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454-1459.
6. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
7. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. Eur Heart J. 1999;20:447-455.
8. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289.
9. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients > or=65 years of age: CHS Research Group Cardiovascular Health Study. Am J Cardiol. 2001;87:413-419.
10. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101:2118-2121.
11. Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-hour ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol. 1994;23:916-925.
12. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA. 1985;254:3449-3453.
13. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects in the human heart. J Am Coll Cardiol. 1995;26:1068-1079.
14. Schulman S, Lakatta EG, Fleg JL. et al. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol. 1992;263: H1932-H1938.
15. Benjamin EJ, Levy D, Anderson KM, et al. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol. 1992;70:508-515.
16. Swinne CJ, Shapiro EP, Lima SD, et al. Age-associated changes in left ventricular diastolic performance during isometric exercise in normal subjects. Am J Cardiol. 1992;69:823-826.
17. Fleg JL, O'Connor FC, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol. 1995:78:890-900.
18. Rodeheffer RJ, Gerstenblith G, Beard E, et al. Postural changes in cardiac volumes in men in relation to adult age. Exp Gerontol. 1986;21:367-378.
19. Fleg JL, Schulman S, O'Connor FC, et al. Effects of acute β-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation. 1994;90:2333-2341.
20. Yin FCP, Raizes GS, Guarnieri T, et al. Age-associated decrease in ventricular response to haemodynamic stress during beta-adrenergic blockade. Brit Heart J. 1978;40:1349-1355.
21. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993;73:413-465.
22. Esler MD, Turner AG, Kaye DM, et al. Ageing effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278-R285.
23. Seals DR, Dempsey JA. Aging, exercise and cardiopulmonary function. In Lamb DR, Gisolfi CV, Nadel E, eds. Perspectives in Exercise Science and Sports Medicine. Vol 8. Carmel, Ind: Cooper Publishing Group; 1995:237-304.
24. Yin FCP, Weisfeldt ML, Milnor WR. Role of aortic input impedance in the decreased cardiovascular response to exercise with aging in dogs. J Clin Invest. 1981;68:28-38.
25. Chen C-H, Ting C-T, Lin S-J, et al. Which arterial and cardiac parameters best predict left ventricular mass? Circulation. 1998;98:422-428.
26. Chen C-H, Nakayama M, Talbot M, et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. J Am Coll Cardiol. 1999;33:1602-1609.
27. Schulman SP, Gerstenblith G, Fleg JL, et al. Relationship of age and sex on ventricular vascular coupling at rest and exercise. Circulation. 2000;102(suppl II):II-602.
28. Nussbacher A, Gerstenblith G, O'Connor F, et al. Hemodynamic effects of unloading the old heart. Am J Physiol. 1999;277:H1863-HI871.
29. Schulman SP, Fleg JL, Busby-Whitehead J, et al. Continuum of cardiovascular performance across a broad range of fitness levels in healthy older men. Circulation. 1996;94:359-367.
30. Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. Circulation. 1996;94:2850-2855.
31. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest. 1982;81:302-307.
32. Fleg JL, Kennedy HL. Long-term prognosis significance of ambulatory electrocardiographic findings in apparently healthy subjects ≥60 years of age. Am J Cardiol. 1992;70:748-751.
33. Gerstenblith G, Fredricksen J, Yin FCP, et al. Echocardiographic assessment of a normal adult aging population. Circulation. 1977;56:273-278.
34. Maurer MS, Shefrin EA, Fleg JL. Prevalence and prognostic significance of exercise-induced supraventricular tachycardia in apparently healthy volunteers. Am J Cardiol. 1995;75:788-792.
35. Busby MJ, Shefrin EA, Fleg JL. Prevalence and long-term significance of exercise-induced frequent or repetitive ventricular ectopic beats in apparently healthy volunteers. J Am Coll Cardiol. 1989;14:1659-1665.
36. Lakatta EG. Aging effects on the vascular in health: risk factors for cardiovascular disease. Am J Geriatr Cardiol. 1994;3:11-17, 50.
37. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation. In press.